vs
Phreesia, Inc.（PHR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Phreesia, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$120.3M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 3.5%，领先380.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 12.7%）
Phreesia, Inc.是一家SaaS服务企业，为医疗机构提供多款应用软件，帮助机构实现患者登记分诊流程的自动化处理与高效管理，助力医疗流程优化，提升机构运营效率与患者就诊体验。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PHR vs RIGL — 直观对比
营收规模更大
PHR
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出8.5%
12.7%
净利率更高
RIGL
高出380.5%
3.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.3M | $69.8M |
| 净利润 | $4.3M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 3.1% | 33.2% |
| 净利率 | 3.5% | 384.0% |
| 营收同比 | 12.7% | 21.2% |
| 净利润同比 | 129.7% | 1769.2% |
| 每股收益（稀释后） | $0.07 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PHRRIGL
| Q4 25 | $120.3M | $69.8M | ||
| Q3 25 | $117.3M | $69.5M | ||
| Q2 25 | $115.9M | $101.7M | ||
| Q1 25 | — | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | — | $55.3M | ||
| Q2 24 | — | $36.8M | ||
| Q1 24 | — | $29.5M |
净利润PHRRIGL
| Q4 25 | $4.3M | $268.1M | ||
| Q3 25 | $654.0K | $27.9M | ||
| Q2 25 | $-3.9M | $59.6M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-8.2M |
毛利率PHRRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率PHRRIGL
| Q4 25 | 3.1% | 33.2% | ||
| Q3 25 | -1.3% | 40.9% | ||
| Q2 25 | -2.8% | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率PHRRIGL
| Q4 25 | 3.5% | 384.0% | ||
| Q3 25 | 0.6% | 40.2% | ||
| Q2 25 | -3.4% | 58.6% | ||
| Q1 25 | — | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | — | -27.9% |
每股收益（稀释后）PHRRIGL
| Q4 25 | $0.07 | $14.11 | ||
| Q3 25 | $0.01 | $1.46 | ||
| Q2 25 | $-0.07 | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $106.4M | $155.0M |
| 总债务越低越好 | $3.4M | $52.5M |
| 股东权益账面价值 | $320.3M | $391.5M |
| 总资产 | $423.5M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.01× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PHRRIGL
| Q4 25 | $106.4M | $155.0M | ||
| Q3 25 | $98.3M | $137.1M | ||
| Q2 25 | $90.9M | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务PHRRIGL
| Q4 25 | $3.4M | $52.5M | ||
| Q3 25 | $4.6M | $60.0M | ||
| Q2 25 | $6.2M | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益PHRRIGL
| Q4 25 | $320.3M | $391.5M | ||
| Q3 25 | $298.0M | $117.6M | ||
| Q2 25 | $282.2M | $81.9M | ||
| Q1 25 | — | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产PHRRIGL
| Q4 25 | $423.5M | $513.6M | ||
| Q3 25 | $408.6M | $242.5M | ||
| Q2 25 | $400.4M | $206.7M | ||
| Q1 25 | — | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $128.4M | ||
| Q1 24 | — | $126.5M |
负债/权益比PHRRIGL
| Q4 25 | 0.01× | 0.13× | ||
| Q3 25 | 0.02× | 0.51× | ||
| Q2 25 | 0.02× | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $12.2M | — |
| 自由现金流率自由现金流/营收 | 10.1% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | 3.62× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PHRRIGL
| Q4 25 | $15.5M | $22.0M | ||
| Q3 25 | $14.8M | $24.0M | ||
| Q2 25 | $14.8M | $30.5M | ||
| Q1 25 | — | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | — | $302.0K | ||
| Q1 24 | — | $-5.0M |
自由现金流PHRRIGL
| Q4 25 | $12.2M | — | ||
| Q3 25 | $13.1M | — | ||
| Q2 25 | $11.3M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率PHRRIGL
| Q4 25 | 10.1% | — | ||
| Q3 25 | 11.1% | — | ||
| Q2 25 | 9.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度PHRRIGL
| Q4 25 | 2.7% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率PHRRIGL
| Q4 25 | 3.62× | 0.08× | ||
| Q3 25 | 22.68× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PHR
| Subscription And Services | $55.5M | 46% |
| Network Solutions | $37.4M | 31% |
| Payment Processing Fees | $27.4M | 23% |
RIGL
暂无分部数据
